相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
Ronald F. van Vollenhoven et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials
Susan Manzi et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Immune Regulatory Function of B Cells
Claudia Mauri et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Dispensability of APRIL to the development of systemic lupus erythematosus in NZM 2328 mice
Chaim O. Jacob et al.
ARTHRITIS AND RHEUMATISM (2012)
Efficacy and Safety of Rituximab in Patients With Active Proliferative Lupus Nephritis The Lupus Nephritis Assessment With Rituximab Study
Brad H. Rovin et al.
ARTHRITIS AND RHEUMATISM (2012)
Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus
Vera Sau-Fong Chan et al.
AUTOIMMUNITY REVIEWS (2012)
Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study
Joan T. Merrill et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Richard Furie et al.
ARTHRITIS AND RHEUMATISM (2011)
Treatment of systemic lupus erythematosus with epratuzumab
Pawel Traczewski et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
SAR3419: An Anti-CD19-Maytansinoid Immunoconjugate for the Treatment of B-Cell Malignancies
Veronique Blanc et al.
CLINICAL CANCER RESEARCH (2011)
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Sandra V. Navarra et al.
LANCET (2011)
Safety and Efficacy of Rituximab in Systemic Lupus Erythematosus
Benjamin Terrier et al.
ARTHRITIS AND RHEUMATISM (2010)
Efficacy and Safety of Rituximab in Moderately-to-Severely Active Systemic Lupus Erythematosus The Randomized, Double-Blind, Phase II/III Systemic Lupus Erythematosus Evaluation of Rituximab Trial
Joan T. Merrill et al.
ARTHRITIS AND RHEUMATISM (2010)
Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression
A. KITANI et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Immunologic abnormality in NZB/W Fl mice. Thymus-independent expansion of B cells responding to interleukin-6
M. MIHARA et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Anti-CD22 Immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-Positive Hematologic Malignancies of Childhood: Preclinical Studies and Phase I Clinical Trial
Alan S. Wayne et al.
CLINICAL CANCER RESEARCH (2010)
IL-6: Regulator of Treg/Th17 balance
Akihiro Kimura et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
Paul A. Blair et al.
IMMUNITY (2010)
CD20 deficiency in humans results in impaired T cell-independent antibody responses
Taco W. Kuijpers et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Regulatory B Cells (B10 Cells) Have a Suppressive Role in Murine Lupus: CD19 and B10 Cell Deficiency Exacerbates Systemic Autoimmunity
Rei Watanabe et al.
JOURNAL OF IMMUNOLOGY (2010)
Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients
M. Garcia-Carrasco et al.
LUPUS (2010)
Evolution of anti-CD20 monoclonal antibody therapeutics in oncology
Ezogelin Oflazoglu et al.
MABS (2010)
Genetic susceptibility to systemic lupus erythematosus in the genomic era
Yun Deng et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
B cells as therapeutic targets in SLE
Inaki Sanz et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Pathogenesis of ankylosing spondylitis
Lai-Shan Tam et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Rituximab as early therapy for pulmonary haemorrhage in systemic lupus erythematosus
Chetan B. Narshi et al.
RHEUMATOLOGY (2010)
Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus
Capucine Daridon et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Systemic Activation of the Immune System Induces Aberrant GAFF and APRIL Expression in B Cells in Patients With Systemic Lupus Erythematosus
Van Trung Chu et al.
ARTHRITIS AND RHEUMATISM (2009)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Belimumab in Patients With Active Systemic Lupus Erythematosus
Daniel J. Wallace et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Rituximab in Severe Lupus Nephritis: Early B-Cell Depletion Affects Long-Term Renal Outcome
Catherine Melander et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Monoclonal Antibodies in the Treatment of Systemic Lupus Erythematosus
Ewa Robak et al.
CURRENT DRUG TARGETS (2009)
Molecular mechanism and function of CD40/CD40L engagement in the immune system
Raul Elgueta et al.
IMMUNOLOGICAL REVIEWS (2009)
Interleukin-6 release from peripheral mononuclear cells is associated to disease activity and treatment response in patients with lupus nephritis
Pasquale Esposito et al.
LUPUS (2009)
Rituximab in systemic lupus erythematosus A systematic review of off-label use in 188 cases
M. Ramos-Casals et al.
LUPUS (2009)
Effective Treatment of Refractory Pulmonary Hemorrhage with Monoclonal Anti-CD20 Antibody (Rituximab)
Luis Fernando Pinto et al.
RESPIRATION (2009)
Treating severe systemic lupus erythematosus with rituximab. An open study
Carlos Abud-Mendoza et al.
REUMATOLOGIA CLINICA (2009)
Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus
D. Albert et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus
Michelle Petri et al.
ARTHRITIS AND RHEUMATISM (2008)
Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus -: Delineation by expression of CD27, IgD, and CD95
Annett M. Jacobi et al.
ARTHRITIS AND RHEUMATISM (2008)
Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis
Oliver M. Steinmetz et al.
KIDNEY INTERNATIONAL (2008)
Mechanisms of disease: Systemic lupus erythematosus
Anisur Rahman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Differential effects of epratuzumab on peripheral blood B cells of patients with systemic lupus erythematosus versus normal controls
A. M. Jacobi et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis:: results from a 10-year longitudinal study
S. W. Syversen et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
BAFF and MyD88 signals promote a lupuslike disease independent of T cells
Joanna R. Groom et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4(+)CD25(+) T cell regulatory functions
Suigui Wan et al.
JOURNAL OF IMMUNOLOGY (2007)
Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus
Bailin Liang et al.
IMMUNOLOGY (2006)
Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF
Chaim O. Jacob et al.
JOURNAL OF IMMUNOLOGY (2006)
Similarities and differences between selective and nonselective BAFF blockade in murine SLE
M Ramanujam et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study
Monica Vigna-Perez et al.
ARTHRITIS RESEARCH & THERAPY (2006)
B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels
CE Collins et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Homeostatic niche specification among naive and activated B cells: A growing role for the BLyS family of receptors and ligands
JE Crowley et al.
SEMINARS IN IMMUNOLOGY (2005)
Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis
SK O'Neill et al.
JOURNAL OF IMMUNOLOGY (2005)
Cross-reactivity of human lupus anti-DNA antibodies with α-actinin and nephritogenic potential
ZG Zhao et al.
ARTHRITIS AND RHEUMATISM (2005)
Distinct profiles of human B cell effector cytokines: A role in immune regulation?
ME Duddy et al.
JOURNAL OF IMMUNOLOGY (2004)
Antihistone and anti-double-stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus
J Cortés-Hernández et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis
F Forger et al.
LUPUS (2004)
Development of autoantibodies before the clinical onset of systemic lupus erythematosus
MR Arbuckle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Pathogenesis of systemic lupus erythematosus
CC Mok et al.
JOURNAL OF CLINICAL PATHOLOGY (2003)
Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis
P Alba et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome
X Mariette et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
The relationship of FcγRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus
JH Anolik et al.
ARTHRITIS AND RHEUMATISM (2003)
The paradigm of IL-6: from basic science to medicine
Tetsuji Naka et al.
ARTHRITIS RESEARCH & THERAPY (2002)
Cutting edge: Ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease
T Higuchi et al.
JOURNAL OF IMMUNOLOGY (2002)
Cutting edge: A role for B lymphocyte stimulator in systemic lupus erythematosus
J Zhang et al.
JOURNAL OF IMMUNOLOGY (2001)
Temperature renormalization of the magnetic excitations in S=1/2 KCuCl3
N Cavadini et al.
EUROPEAN PHYSICAL JOURNAL B (2000)
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
JA Gross et al.
NATURE (2000)
CD19 regulates intrinsic B lymphocyte signal transduction and activation through a novel mechanism of processive amplification
M Fujimoto et al.
IMMUNOLOGIC RESEARCH (2000)
分享论文
